Mesa Laboratories Inc (MLAB)
Profitability ratios
Return on sales
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 61.64% | 61.02% | 60.49% | 60.90% | 61.02% | 61.47% | 58.79% | 58.95% | 58.97% | 60.41% | 63.50% | 63.98% | 64.97% | 62.26% | 58.90% | 57.28% | 55.54% | 56.59% | 60.06% | 59.48% |
| Operating profit margin | -125.85% | -0.13% | 1.50% | 3.31% | 1.52% | 1.71% | -1.90% | -2.06% | 3.84% | 5.57% | 8.15% | 8.57% | 9.23% | 6.98% | 4.55% | 4.97% | 6.68% | 8.54% | 13.31% | 9.98% |
| Pretax margin | -127.50% | -0.28% | -0.29% | 1.86% | -0.18% | -0.10% | -2.69% | -2.31% | 2.85% | 5.21% | 3.59% | 2.14% | 1.72% | 13.32% | 14.00% | 15.78% | 20.18% | 18.20% | 24.92% | 22.82% |
| Net profit margin | -117.60% | 0.45% | -0.34% | 0.83% | 0.42% | 0.20% | -1.34% | 0.16% | 2.91% | 4.64% | 3.56% | 2.92% | 2.44% | 13.82% | 14.03% | 15.07% | 18.41% | 16.96% | 22.99% | 21.16% |
Mesa Laboratories Inc's profitability ratios have shown some fluctuations over the past few quarters. The gross profit margin has remained relatively stable, ranging between 58.79% and 64.97%. This indicates the company's ability to efficiently generate profits from its revenue after accounting for the cost of goods sold.
However, the operating profit margin has displayed more volatility, with significant fluctuations from negative figures to positive figures. This suggests that Mesa Laboratories Inc has experienced variability in its operating expenses and efficiency in managing its operational costs.
The pretax margin has also exhibited fluctuations, with several quarters of negative margins interspersed with positive margins. This volatility may reflect changes in the company's sales, expenses, and other financial factors impacting its pre-tax profitability.
In terms of net profit margin, Mesa Laboratories Inc has recorded positive margins in most quarters, indicating its ability to generate profits after accounting for all expenses and taxes. The variability in net profit margins may be influenced by factors such as changes in operating expenses, taxes, and other one-time items impacting the bottom line.
Overall, while Mesa Laboratories Inc has shown varying levels of profitability across different quarters, it is important for the company to focus on maintaining stable and sustainable profitability ratios to ensure long-term financial health and performance.
Return on investment
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -60.89% | -0.04% | 0.50% | 1.13% | 0.50% | 0.42% | -0.47% | -0.42% | 0.68% | 1.26% | 1.91% | 1.94% | 2.05% | 1.46% | 0.99% | 1.05% | 1.92% | 2.22% | 3.56% | 6.52% |
| Return on assets (ROA) | -56.90% | 0.13% | -0.11% | 0.28% | 0.14% | 0.05% | -0.33% | 0.03% | 0.52% | 1.05% | 0.84% | 0.66% | 0.54% | 2.89% | 3.04% | 3.17% | 5.30% | 4.40% | 6.15% | 13.82% |
| Return on total capital | -85.27% | 0.80% | 0.69% | 1.59% | 0.78% | 0.80% | 0.01% | 0.15% | 1.34% | 2.15% | 1.93% | 1.75% | 1.87% | 0.76% | 0.89% | 0.98% | 2.18% | 2.51% | 3.80% | 8.43% |
| Return on equity (ROE) | -174.87% | 0.24% | -0.18% | 0.47% | 0.24% | 0.08% | -0.59% | 0.06% | 0.93% | 1.91% | 1.28% | 1.02% | 0.81% | 4.36% | 4.56% | 4.79% | 9.85% | 7.92% | 10.48% | 18.53% |
Mesa Laboratories Inc's profitability ratios have shown significant fluctuations over the periods analyzed. The Operating return on assets (Operating ROA) has been negative in recent quarters, indicating that the company is not efficiently generating profits from its assets and operations. Similarly, the Return on assets (ROA) has also been inconsistent, with some periods showing positive returns while others are negative.
The Return on total capital has also varied, reflecting the company's ability to generate returns from both equity and debt sources. However, it has generally been lower than the Return on assets, indicating potential inefficiencies in capital utilization. The Return on equity (ROE) has followed a similar trend, with fluctuations in profitability levels over the periods.
Overall, Mesa Laboratories Inc's profitability ratios demonstrate the need for improved operational efficiency and capital utilization to enhance overall profitability and shareholder value. Further analysis and strategic adjustments may be necessary to address the fluctuations in profitability seen in the financial statements.